FindTrial
Sign In

Aikenist MRI Enhancement Software Quickscan Clinical Trial

Performance Analysis of Aikenist MRI/CT Enhancement Software Quickscan

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/01/049285
Enrollment
500
Registered
2023-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G998- Other specified disorders of nervous system in diseases classified elsewhere

Interventions

Control Intervention1: NIL: NIL

Sponsors

Aikenist Technologies Pvt. Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Gender ratio: 50:50 (Male: Female) Age group: 2-20, 20-60, 60+

Exclusion criteria

Exclusion criteria: Fetal and heart MRI scans

Design outcomes

Primary

MeasureTime frame
Analysis of Aikenist processed MRI/CT scans with original MRI/CT scans from the blind study from collected brain, MSK,spine and abdomen MRI images subjectively by radiologists Aikenist Technologies Pvt Limited One must reject the null hypothesis if there is a significant difference in Aikenist processed image when an average is less than or equal to 0.5 Likert scale points by radiologists.Timepoint: 15 days once—

Secondary

MeasureTime frame
Evaluation of Quickscan processed scans and standard of care scansTimepoint: one week once—

Countries

India

Contacts

Public ContactDr Rudresh Hiremath

JSS Medical College Mysore

rudreshhiremath@jssuni.edu.in8970137697

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026